Voyager Therapeutics, Inc.Voyager Therapeutics, Inc.Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.

No trades
See on Supercharts

VYGR fundamentals

Voyager Therapeutics, Inc. key financial stats and ratios

VYGR price-to-sales ratio is 1.37. The company has an Enterprise Value to EBITDA ratio of 1.67. As of 2023 they employed 162.00 people.

Statistics
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Price to earnings ratio
Price to cash flow ratio
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios